Farhad Ravandi - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Farhad Ravandi's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Farhad Ravandi

Farhad Ravandi

Verified

Editorial Board Member, Blood Cancer Journal

Final Covers

Health, Politics, Current Events , Drawing, Art, Science , Photography

Doesn’t Cover

I do not cover topics, which exploit or bring harm to anyone or communities.

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 62

  • Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients - Blood Cancer Journal

    By Christophe Willekens, Alex Bataller, Caitlin R Rausch, Nicholas Short, Koji Sasaki, Mahesh Swaminathan, Jean-Baptiste Micol, Tapan M Kadia, Farhad Ravandi, Arnaud Pagès, Hagop Kantarjian

    Apr. 16, 2025

  • Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia - Bone Marrow Transplantation

    By Jayastu Senapati, Guillermo Garcia-Manero, Courtney DiNardo, Gautam Borthakur, Tapan M Kadia, Elias Jabbour, Nicholas Short, Hussein Abbas, Naveen Pemmaraju, Uday Popat, Sanam Loghavi, Guilin Tang, Farhad Ravandi, Hagop Kantarjian

    Apr. 10, 2025

  • Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients - Blood Cancer Journal

    By Christophe Willekens, Alex Bataller, Caitlin R Rausch, Nicholas Short, Koji Sasaki, Mahesh Swaminathan, Jean-Baptiste Micol, Tapan M Kadia, Farhad Ravandi, Arnaud Pagès, Hagop Kantarjian

    Apr. 16, 2025

As seen in

Company Info

Blood Cancer Journal

Hoboken, New Jersey, United States

'+1 201-748-6000

Founded: